# (Presolicitation Notice) Intent to Sole Source - Biol Specimens for Lenacapavir PEP Canonical: https://abierto.us/opportunities/pr97866 - Solicitation number: PR97866 - Notice type: Presolicitation - Status: Open. Offers due September 17, 2026 at 6:00 AM EDT - Department: Department of Health and Human Services - Agency: Centers for Disease Control and Prevention - Contracting office: CDC Office of Acquisition Services (75D301) - NAICS: 621511 Medical Laboratories - Product or service code: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets - Place of performance: Atlanta, Georgia - First posted: September 3, 2026 - Last posted: September 3, 2026 - SAM.gov: https://sam.gov/workspace/contract/opp/812e656801b04b8eb23982cbd971fe05/view ## Description The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Emory University for the procurement and delivery of biological specimens from persons receiving weekly oral lenacapavir. Emory maintains established HIV clinical-research infrastructure, including HIV prevention and treatment clinical-research capabilities, and has documented prior experience performing CDC-supported clinical studies involving extensive biological specimen collection and pharmacokinetic-related procedures. Emory also has prior CDC DHP contract performance and documented experience with the collection, processing, handling, and transfer of biological specimens required for CDC-supported research. This established experience provides continuity with CDC DHP laboratory methods and specimen-handling procedures and reduces technical risk associated with protocol implementation, specimen-processing method transfer, study start-up, and preservation of specimen integrity. In addition, Emory’s Atlanta-area location permits timely and predictable monthly transport of specimens to the CDC DHP Laboratory Branch. This proximity reduces cold-chain transportation time, shipping variability, weather-related exposure, and other risks that could adversely affect specimen integrity and comparability. This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of RFO FAR 12.201-1 simplified procedures pursuant to 41 U.S.C. 1901, and is justified under 41 U.S.C. 3304(a)(1). See note below. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within 15 of days of the issuance of this notice shall be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at xmr1@cdc.gov, by the closing date of this posting. ## Publications - September 3, 2026: Presolicitation, due September 17, 2026 at 6:00 AM EDT. Notice 812e656801b04b8eb23982cbd971fe05. https://sam.gov/workspace/contract/opp/812e656801b04b8eb23982cbd971fe05/view ## Points of contact - Shamike Bethea, Xrm1@cdc.gov --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/pr97866.